Articles published by UroGen Pharma Ltd.
![](https://mms.businesswire.com/media/20221201005672/en/1652600/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20221121005687/en/1644076/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20221114005232/en/1634905/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20221110005284/en/1632178/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
November 10, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20221109005287/en/1630388/5/UroGen_logo2_%28R%29_%28002%29.jpg)
UroGen Announces the Appointment of Dan Wildman to the UroGen Pharma Board of Directors
November 09, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20221103005311/en/1623587/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
November 03, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20221011005425/en/1597571/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma to Host Thought Leader Webinar on UGN-102 and Non-Muscle Invasive Bladder Cancers
October 11, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220928005322/en/1585021/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20220912005156/en/1567349/5/UroGen_logo2_%28R%29_%28002%29.jpg)
UroGen Announces the Appointment of Dr. Leana S. Wen to the UroGen Pharma Board of Directors
September 12, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220909005063/en/1566468/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220907006069/en/1564292/5/UroGen_logo2_%281%29.jpg)
UroGen Pharma Announces Upcoming 2022 Conferences
September 07, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220811005112/en/1541272/5/UroGen_logo2_%281%29.jpg)
UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
August 11, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220727005288/en/1525573/5/UroGen_logo2_%281%29.jpg)
UroGen Pharma to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
July 27, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220603005009/en/1471845/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220518005277/en/1459186/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220516005726/en/1456620/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220513005093/en/1454590/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220510005510/en/1449282/5/UroGen_logo2_%281%29.jpg)
UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Developments
May 10, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220503005426/en/1440609/5/UroGen_logo2_%281%29.jpg)
![](https://mms.businesswire.com/media/20220329005373/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20220321005260/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20220228005334/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference
February 28, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20220210005222/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20220202005169/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20220105005366/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
UroGen Pharma to Present at Upcoming Conferences
January 05, 2022
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20211221005140/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20211203005040/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
![](https://mms.businesswire.com/media/20211115005427/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
November 15, 2021
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20211111005641/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
UroGen Pharma Announces Upcoming 2021 Conferences
November 11, 2021
From UroGen Pharma Ltd.
Via Business Wire
Tickers
URGN
![](https://mms.businesswire.com/media/20211110005855/en/706812/5/UroGen_Logo_with_TM_02.06.19.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.